Perceptive Advisors LLC Horizon Therapeutics Public LTD CO Transaction History

Perceptive Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $59.9 Million - $109 Million	960,000 New	960,000 $109 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $108 Million - $158 Million	-1,357,903 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $32.9 Million - $41.8 Million	-380,237 Reduced 21.88%	1,357,903 $143 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $21.6 Million - $26.2 Million	-218,800 Reduced 11.18%	1,738,140 $187 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $2.58 Million - $3.1 Million	-28,062 Reduced 1.41%	1,956,940 $214 Million

Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $5.61 Million - $6.23 Million	-65,000 Reduced 3.17%	1,985,002 $186 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $74.3 Million - $98.7 Million	-1,034,040 Reduced 33.53%	2,050,002 $189 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $207 Million - $260 Million	3,084,042 New	3,084,042 $226 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.